Europital, founded in 2010, is headquartered in Belgium and operates as an international, science-driven, Medical Contract Research Organization (CRO). The company excels in providing comprehensive medical services across all phases of drug and medical device development, collaborating with clients in the pharmaceutical, biotechnology, and medical device industries, as well as governmental and scientific institutes.
Europital’s unique approach integrates a scientific mindset with methodical and creative solutions, ensuring high-quality service delivery. Their areas of expertise include medical management of clinical trials, study design, and conduct, and management of protocol deviations, among others. The firm has extensive experience across various therapeutic areas, notably in Oncology, Infectious Diseases, Cardiology, and Immunology.
Despite the absence of recent investment activity, Europital maintains its competitive edge through a commitment to quality, efficiency, and operational excellence, making it a reliable partner for clinical projects globally.